CWC
TECH icon

Carolinas Wealth Consulting’s Bio-Techne TECH Stock Holding History

Carolinas Wealth Consulting’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-45
Closed -$2.62K – 841
2025
Q1 		$2.62K Sell
45
-5
-10% -$339 ﹤0.01% 742
2024
Q4 		$3.58K Buy
50
+21
+72% +$1.54K ﹤0.01% 693
2024
Q3 		$2.24K Buy
29
+3
+12% +$225 ﹤0.01% 794
2024
Q2 		$1.83K Buy
26
+12
+86% +$883 ﹤0.01% 819
2024
Q1 		$977 Buy
+14
New +$1K ﹤0.01% 900
2023
Q4 		– Sell
-28
Closed -$1.53K – 1052
2023
Q3 		$1.53K Hold
28
– – ﹤0.01% 770
2023
Q2 		$2.29K Hold
28
– – ﹤0.01% 792
2023
Q1 		$2.08K Sell
28
-664
-96% -$51.2K ﹤0.01% 807
2022
Q4 		$57.4K Buy
692
+140
+25% +$11.1K 0.01% 330
2022
Q3 		$39K Sell
552
-48
-8% -$4.15K 0.01% 361
2022
Q2 		$52K Buy
600
+84
+16% +$7.87K 0.01% 325
2022
Q1 		$56K Buy
516
+12
+2% +$1.24K 0.01% 334
2021
Q4 		$65K Buy
504
+312
+163% +$38.2K 0.01% 329
2021
Q3 		$23K Sell
192
-32
-14% -$3.89K 0.01% 453
2021
Q2 		$25K Sell
224
-4
-2% -$421 0.01% 466
2021
Q1 		$22K Buy
+228
New +$20.8K 0.01% 496

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Carolinas Wealth Consulting's TECH Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Bio-Techne (TECH) in Q2 2025, closing a stake of 45 shares — an estimated $2.62K sold.

Carolinas Wealth Consulting first reported a position in TECH in Q1 2021 and held it in 16 quarters. The position peaked at $65K in Q4 2021. 556 funds tracked by Wall St. Rank hold TECH as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Bio-Techne position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 45 Bio-Techne shares in Q2 2025, an estimated $2.62K.
  • Carolinas Wealth Consulting first reported a position in Bio-Techne in Q1 2021 and held it in 16 quarters.
  • Carolinas Wealth Consulting's Bio-Techne position peaked at $65K in Q4 2021.
  • 556 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.